Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2006
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaKerrie Tosh, Sarah J Campbell, Katherine Fielding, et al.
Immunogenetics|September 5, 2003
Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West AfricaSarah J Campbell, Pardis Sabeti, Katherine Fielding, et al.
The Journal of Infectious Diseases|October 13, 2004
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family studyLiza Bornman, Sarah J Campbell, Katherine Fielding, et al.
Plos One|May 26, 2016
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research AgendaCarole D Mitnick, Carly A Rodriguez, Marita L Hatton, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2021
Evidence-based Definition for Extensively Drug-Resistant TuberculosisMaroussia Roelens, Giovanni Battista Migliori, Liudmila Rozanova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 13, 2024
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024Dominique Ploin, Mathilde Alexandre, Bruno Ventelou, et al.
The Lancet. Infectious Diseases|March 28, 2013
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for actionWilliam A Wells, Catharina C Boehme, Frank G J Cobelens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 23, 2023
Recent advances in the treatment of tuberculosisIlaria Motta, Martin Boeree, Dumitru Chesov, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Plos One|January 3, 2008
CD209 genetic polymorphism and tuberculosis diseaseFredrik O Vannberg, Stephen J Chapman, Chiea C Khor, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2006
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaKerrie Tosh, Sarah J Campbell, Katherine Fielding, et al.
Immunogenetics|September 5, 2003
Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West AfricaSarah J Campbell, Pardis Sabeti, Katherine Fielding, et al.
The Journal of Infectious Diseases|October 13, 2004
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family studyLiza Bornman, Sarah J Campbell, Katherine Fielding, et al.
Plos One|May 26, 2016
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research AgendaCarole D Mitnick, Carly A Rodriguez, Marita L Hatton, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2021
Evidence-based Definition for Extensively Drug-Resistant TuberculosisMaroussia Roelens, Giovanni Battista Migliori, Liudmila Rozanova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 13, 2024
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024Dominique Ploin, Mathilde Alexandre, Bruno Ventelou, et al.
The Lancet. Infectious Diseases|March 28, 2013
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for actionWilliam A Wells, Catharina C Boehme, Frank G J Cobelens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 23, 2023
Recent advances in the treatment of tuberculosisIlaria Motta, Martin Boeree, Dumitru Chesov, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Plos One|January 3, 2008
CD209 genetic polymorphism and tuberculosis diseaseFredrik O Vannberg, Stephen J Chapman, Chiea C Khor, et al.
Pageof 12